Unique Immediate Release Technology

A patented technology used for developing Potafast, characterized by the unique blending of excipients and a special ratio between Diclofenac and Bicarbonate, that creates a microenvironmental at gastro-intestinal level, to ensure more rapid and regular absorption and faster onset of action of Potafast compared with conventional preparations.